Correction to “Targeted Co‐Delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer”

In the initially published version of this article, inadvertent duplications occurred in the immunofluorescence images (Figure 5, c-PARP, Blank group, and free siTR3group) and in vivo fluorescence images (Figure 6, PSPG/PTX/siRNA group, 12 and 24 h) during the figure preparation process.The authors identified the mistake, and the corrected Figures 5 and6 are as follows:Figure 5.In vitro immunofluorescence image of Panc-1 cells transfected with free siTR3, PSPG/siTR3, and PSPGP/siTR3 at 24 h.Nur77, Bcl-2, Survivin, c-Caspase, and c-PARP were labeled with the corresponding antibody, and the secondary antibody (green) was